Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00881764 · ClinicalTrials.gov registry record
PANDA (Pediatric Anesthesia & NeuroDevelopment Assessment) Study
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 369
- Enrollment target
NCT00881764: Completed study, sponsored by Columbia University.
NCT00881764 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 369 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00881764 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 369 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the use of anesthetic agents in infants and children have long term adverse effects on neurocognitive development. According to the National Hospital Discharge Survey, around 2.5 million children have surgical procedures requiring anesthesia each year in the US. Recent animal studies have suggested that the exposure of the immature organism to a variety of commonly used anesthetic agents may lead to neurobehavioral functional deficits in vivo and to neuronal apoptosis in vitro. While the relevance of these findings on children exposed to anesthetics remains to be determined, it is clearly critically important to public health that this issue is resolved quickly and clearly. Hypothesis: Exposure to anesthetic agents within the first three years of life will not significantly impair cognitive functions at ages 8 yr, 0 mo to 15 yr, 0 mo.
Primary Outcome
Global cognitive function: verbal, performance and full IQ assessed by Wechsler Abbreviated Scale of Intelligence (WASI). These are one unit of measure for IQ.
Interventions
- PROCEDURE Inguinal hernia surgery
- PROCEDURE General anesthesia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 369 participants |
| Start Date | 2009-05 |
| Est. Completion | 2016-01 |
What the finished NCT00881764 record still lists
NCT00881764 is an observational study that tracks outcomes without assigning an intervention. The registered 369 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Inguinal hernia surgery is the first listed.
NCT00881764 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00881764 about?
NCT00881764 is a clinical study titled "PANDA (Pediatric Anesthesia & NeuroDevelopment Assessment) Study". The purpose of this study is to determine whether the use of anesthetic agents in infants and children have long term adverse effects on neurocognitive development. According to the National Hospital Discharge Survey, around 2.5 million children have surgical procedures requiring anesthesia each yea...
What is the current status of trial NCT00881764?
This trial is currently completed. The enrollment target is 369 participants. The study started on 2009-05. Estimated completion is 2016-01.
What interventions are being tested in trial NCT00881764?
The interventions under investigation include: Inguinal hernia surgery (PROCEDURE), General anesthesia (PROCEDURE).
Who is sponsoring clinical trial NCT00881764?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06114836 · 369 participants · NA
GERD Infant Feeding Therapeutics Trial (GIFT Trial)
- NCT06585410 · 369 participants · Phase 3
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
- NCT07256717 · 369 participants · NA
BPIT 5-Week Multi-Site Study: Movement Efficiency, Mobility & Neuromuscular Adaptation
- NCT02332668 · 370 participants · Phase 1
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia